The independent source for health policy research, polling, and news.
141 - 160 of 592 Results
Research has consistently found that, overall, U.S. prescription drug prices are significantly higher, sometimes two to four times as high, compared with prices in other high-income industrialized countries. However, some market factors can obscure actual prices, making comparisons harder.
The presidential election is likely to turn on the simple question of whether Americans want Donald Trump back in the White House. But health care tops the list of household financial worries for adults from both parties.
A March 5 ballot initiative seeks $6.4 billion to build thousands of new housing units and provide mental health treatment for homeless people — on top of the billions already being spent to address the public health crisis. Despite significant support from health and law enforcement officials, many front-line workers are skeptical that more money is the answer.
In a first-of-its-kind ruling, the Alabama Supreme Court has determined that embryos created for in vitro fertilization procedures are legally people. The decision has touched off massive confusion about potential ramifications, and the University of Alabama-Birmingham has paused its IVF program. Meanwhile, former President Donald Trump is reportedly planning to endorse a national 16-week abortion ban, while his former administration officials are planning further reproductive health restrictions for a possible second term. Lauren Weber of The Washington Post, Rachana Pradhan of KFF Health News, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Opposition to vaccines and other public health measures backed by science has become politically charged. That makes dangerous misinformation much harder to fight.
New Hampshire voters have spoken, and it seems increasingly clear that this November’s election will pit President Joe Biden against former President Donald Trump. Both appear to be making health a key part of their campaigns, with Trump vowing (again) to repeal the Affordable Care Act, and Biden stressing his support for contraception and abortion rights. Meanwhile, both candidates will try to highlight efforts to rein in prescription drug prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Jessie Hellmann of CQ Roll Call join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Sarah Somers of the National Health Law Program about the potential consequences for the health care system if the Supreme Court overturns a key precedent attempting to balance executive vs. judicial power.
New Hampshire’s primary election was dominated by voters’ feelings about Donald Trump. But health care remains a concern — and for Democrats, preserving abortion access is a priority.
Health policy during Donald Trump’s tenure was dominated by covid-19 and a failed effort to repeal and replace the Affordable Care Act. His appointments to the Supreme Court led to the end of national abortion rights, and he took steps to increase hospital price transparency and improve care for veterans.
Former South Carolina Gov. Nikki Haley’s tenure in the Palmetto State — which overlapped with several tumultuous years of health care reform — and her recent comments offer clues to how her presidency might affect national health care policy.
With days to go until a large chunk of the federal government runs out of money needed to keep it operating, Congress is still struggling to find a compromise spending plan. Meanwhile, the Supreme Court agreed to hear — this year — a case that pits federal requirements for emergency treatment against state abortion bans. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Tami Luhby of CNN join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews American Medical Association President Jesse Ehrenfeld about the choppy waters facing the nation’s physicians in 2024.
The fifth debate of the 2024 GOP presidential primary season took place days before Iowa Republicans will caucus to determine their pick for the top of the party’s ticket. The front-runner, former President Donald Trump, once again did not participate.
Debate and speculation are heating up over whether Robert F. Kennedy Jr.’s presidential campaign will factor into the outcome of the 2024 election. But one thing is clear: Kennedy’s political following is built on a movement that seeks to legitimize conspiracy theories.
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of KFF Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.
Obamacare had its moment, but not until the faceoff’s final minutes. Front-runner Donald Trump again was not on the debate stage, leaving the other Republican presidential hopefuls to slug it out to break through and gain voters’ attention.
The two governors exchanged heated verbal barbs when they faced off in a wide-ranging debate that covered various health-related topics, from abortion to gun violence.
Although Republicans have never united behind a replacement for the Affordable Care Act, 2024 GOP presidential front-runner Donald Trump said this week he wants to put the issue back on the national agenda. That delights Democrats, who have won at least two elections partly by defending the now-popular health law. Meanwhile, the Texas Supreme Court takes up a case brought by women who say their pregnancy complications further endangered their health due to the vagueness of Texas’ near-total ban on abortions. Joanne Kenen of Johns Hopkins University and Politico Magazine, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of Axios News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Rachana Pradhan, who reported and wrote the latest “Bill of the Month” feature.
Candidates see former President Donald Trump’s embrace of his administration’s covid-19 vaccine policies as an opportunity to gain ground. So far, their efforts haven’t found traction.
© 2026 KFF